Summit therapeutics reports inducement grants under nasdaq listing rule 5635(c)(4)

Miami--(business wire)---- $smmt--summit therapeutics inc. (nasdaq: smmt) ("summit," "we," or the "company") today announced the grant of inducement awards of options to purchase a collective total of up to 145,550 shares of common stock. awards were made to nine new employees of the company. the awards were granted as an inducement material to the new employees becoming employees of the company in accordance with nasdaq listing rule 5635(c)(4) and have been approved by the company's compensation committ.
NDAQ Ratings Summary
NDAQ Quant Ranking